Related references
Note: Only part of the references are listed.Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity
K. A. Bain et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Impact of antipsychotic medication on IL-6/STAT3 signaling axis in peripheral blood mononuclear cells of drug-naive schizophrenia patients
Manjula Subbanna et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2020)
Differences in the immune-inflammatory profiles of unipolar and bipolar depression
Andre R. Brunoni et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Using psychoneuroimmunity against COVID-19
Sung-Wan Kim et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Altered behavior in mice overexpressing soluble ST2
Motoshi Kikuchi et al.
MOLECULAR BRAIN (2020)
Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study
Shinsuke Hidese et al.
TRANSLATIONAL PSYCHIATRY (2020)
Association between Mental Disorders and Subsequent Medical Conditions
N. C. Momen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Role of Alarmins in the Pathogenesis of Systemic Sclerosis
Antonello Giovannetti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Increased inflammatory biomarkers and changes in biological rhythms in bipolar disorder: A case-control study
Daniela Bavaresco et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Glial and neuronal markers in bipolar disorder: A meta -analysis testing S100B and NSE peripheral blood levels
Francesco Bartoli et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)
Oxidative stress involvement in psoriasis: a systematic review
Serafinella Patrizia Cannavo et al.
FREE RADICAL RESEARCH (2019)
Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses
Ning Yuan et al.
TRANSLATIONAL PSYCHIATRY (2019)
Plasma and cerebrospinal fluid inflammatory cytokines in perinatal depression
Emily S. Miller et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2019)
Do Alarmins Have a Potential Role in Autism Spectrum Disorders Pathogenesis and Progression?
Eleonora Di Salvo et al.
BIOMOLECULES (2019)
Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial
Manish K. Jha et al.
PHARMACEUTICALS (2019)
Interleukin-33 serum levels in postmenopausal women with osteoporosis
Lia Ginaldi et al.
SCIENTIFIC REPORTS (2019)
HMGB1 involved in stress-induced depression and its neuroinflammatory priming role: a systematic review
Huifeng Zhang et al.
GENERAL PSYCHIATRY (2019)
The association between inflammatory markers (iNOS, HO-1, IL-33, MIP-1 beta) and depression with and without posttraumatic stress disorder
Ewa A. Oglodek et al.
PHARMACOLOGICAL REPORTS (2018)
Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression
Andre R. Brunoni et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
Milica M. Borovcanin et al.
FRONTIERS IN PSYCHIATRY (2018)
A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients
Pavani Sayana et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Behavioral Changes in Mice Lacking Interleukin-33
Eisuke Dohi et al.
ENEURO (2017)
Serum levels of interleukin-33 and its soluble form receptor (sST2) are associated with cognitive performance in patients with schizophrenia
Salvina Maria de Campos-Carli et al.
COMPREHENSIVE PSYCHIATRY (2017)
Multiple inflammasome complexes are activated in autistic spectrum disorders
Marina Saresella et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review
Egidio Imbalzano et al.
HEART FAILURE REVIEWS (2016)
Cross-Species Evidence for the Role of Interleukin-33 in Depression Risk
Anastacia Y. Kudinova et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2016)
Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: A preliminary study
Izabela Guimardes Barbosa et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Association between HMGB1 and COPD: A Systematic Review
Sebastiano Gangemi et al.
MEDIATORS OF INFLAMMATION (2015)
Adipokines as emerging depression biomarkers: A systematic review and meta-analysis
Andre F. Carvalho et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
Relationship between Interleukin-6 Gene Polymorphism and Hippocampal Volume in Antipsychotic-Naive Schizophrenia: Evidence for Differential Susceptibility?
Sunil Vasu Kalmady et al.
PLOS ONE (2014)
Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
Masahiro Nitta et al.
SCHIZOPHRENIA BULLETIN (2013)
Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression
Yang Liu et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Nonsteroidal Anti-Inflammatory Drugs in Schizophrenia: Ready for Practice or a Good Start? A Meta-Analysis
Iris E. Sommer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Aberrant Immune Responses in a Mouse with Behavioral Disorders
Yong Heo et al.
PLOS ONE (2011)
The prevalence of depression symptoms and influencing factors among perimenopausal and postmenopausal women
Sermin Timur et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2010)
Share Paper
